Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
about
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.Perinatal Taurine Imbalance Followed by High Sugar Intake Alters the Effects of Estrogen on Renal Excretory Function in Adult Female Rats.Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.Recent Advances in the Neoadjuvant Treatment of Breast Cancer.Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer.The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy.Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.Best Practices for Genomic Assay Testing in Early-Stage Breast Cancer: Clinical and Medicolegal Perspectives.Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells.Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Pre-operative Endocrine Therapy.From Experiment to Theory: What Can We Learn from Growth Curves?From Standard of Care to the Neoadjuvant Model as an Innovative Platform for Exploring Promising Combinations in Breast Cancer
P2860
Q37689013-C1FC5DB9-1957-44FB-A492-ACD5B704AF56Q38604322-D900A910-914C-4B7F-B462-67491E68FFA8Q38658509-2AE4D816-1E75-423F-B0CA-6B27BE36EAABQ38687392-EAC8E14D-AA1D-4662-BA8F-E1787D16C3A9Q38696564-A8B9B1AD-297A-424D-976E-D7A93B4810BDQ38765017-C2C42A55-47A3-42A9-931A-0D91B45DB3A4Q39279806-DAAC499F-3EAF-4A83-A666-FE40F0712C14Q39299810-1D210497-1344-4B01-936E-E55659DEE2FEQ39375196-83140BFD-571E-420E-8B63-97B0404B8314Q41467691-7A86CE59-150D-42C8-8DCF-BA997A498A0DQ43730260-47C60459-22D5-4035-AC93-A9113E7914ABQ45057063-E8F65A78-49C7-48C0-B454-C52AABD456A2Q46143861-8ED02E33-172D-496D-97CF-85708166C9EBQ47576047-778D668C-2E0B-4558-B064-9FC605846312Q57495771-377E66FC-9341-4877-A018-D0A337482640
P2860
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neoadjuvant Endocrine Therapy ...... atic Review and Meta-analysis.
@en
type
label
Neoadjuvant Endocrine Therapy ...... atic Review and Meta-analysis.
@en
prefLabel
Neoadjuvant Endocrine Therapy ...... atic Review and Meta-analysis.
@en
P2093
P2860
P1433
P1476
Neoadjuvant Endocrine Therapy ...... matic Review and Meta-analysis
@en
P2093
Aditya Bardia
Arjun Gupta
Beverly Moy
Kerry L Reynolds
Leif W Ellisen
Michele A Gadd
Steven J Isakoff
P2860
P304
P356
10.1001/JAMAONCOL.2016.1897
P577
2016-11-01T00:00:00Z